5-Fluorouracil Treatment in Chinese Cancer Patients
Author Information
Author(s): D. P. S. Chan, J. H. C. Ho, A. W. T. Woo
Primary Institution: Queen Mary Hospital, Hong Kong
Hypothesis
Does 5-fluorouracil (5FU) effectively palliate advanced solid cancers in Chinese patients?
Conclusion
5FU showed promising results in treating various advanced solid cancers in Chinese patients, with a notable response in breast cancer cases.
Supporting Evidence
- 5 out of 8 breast cancer patients showed good objective response to 5FU treatment.
- Only 3 out of 8 patients with objective response experienced significant side effects.
- The overall duration of remission ranged from 2 to 13 months, averaging 6.5 months.
Takeaway
Doctors gave a medicine called 5FU to help sick people with cancer feel better, and many of them did feel better for a while.
Methodology
28 Chinese patients with advanced solid cancers were treated with 5FU, administered intravenously, and monitored for responses and side effects.
Potential Biases
The study may be biased due to the exclusion of patients who died shortly after treatment began.
Limitations
The small sample size limits the generalizability of the findings.
Participant Demographics
28 Chinese patients, 23 females and 5 males, aged 28 to 75.
Want to read the original?
Access the complete publication on the publisher's website